OSCR
Overvalued by 215.5% based on the discounted cash flow analysis.
Market cap | $4.22 Billion |
---|---|
Enterprise Value | $1.92 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $0.11 |
Beta | 1.86 |
Outstanding Shares | 253,417,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -26.19 |
---|---|
PEG | 5.17 |
Price to Sales | 0.44 |
Price to Book Ratio | 4.6 |
Enterprise Value to Revenue | 0.18 |
Enterprise Value to EBIT | -15.02 |
Enterprise Value to Net Income | -12 |
Total Debt to Enterprise | 0.16 |
Debt to Equity | 0.26 |
No data
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...